Abbott Laboratories (ABT) revealed a profit for its fourth quarter that increased from last year in line with the Street estimates.
The company's bottom line totaled $9.229 billion, or $5.27 per share. This compares with $1.594 billion, or $0.91 per share, last year.
Excluding items, Abbott Laboratories reported adjusted earnings of $2.349 billion or $1.34 per share for the period.
Analysts on average had expected the company to earn $1.34 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 7.2% to $10.974 billion from $10.241 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings: $9.229 Bln. vs. $1.594 Bln. last year.-EPS: $5.27 vs. $0.91 last year.-Revenue: $10.974 Bln vs. $10.241 Bln last year.
-Guidance:Next quarter EPS guidance: $1.05 to $1.09
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.